Sandro Cosconati

5.4k total citations · 1 hit paper
136 papers, 4.3k citations indexed

About

Sandro Cosconati is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sandro Cosconati has authored 136 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 30 papers in Organic Chemistry and 19 papers in Oncology. Recurrent topics in Sandro Cosconati's work include DNA and Nucleic Acid Chemistry (20 papers), Advanced biosensing and bioanalysis techniques (20 papers) and RNA Interference and Gene Delivery (18 papers). Sandro Cosconati is often cited by papers focused on DNA and Nucleic Acid Chemistry (20 papers), Advanced biosensing and bioanalysis techniques (20 papers) and RNA Interference and Gene Delivery (18 papers). Sandro Cosconati collaborates with scholars based in Italy, Germany and United States. Sandro Cosconati's co-authors include Ettore Novellino, Luciana Marinelli, Arthur J. Olson, David S. Goodsell, R. Harris, Stefano Forli, Federico Da Settimo, Antonio Randazzo, Vittorio Limongelli and Giorgio Amendola and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nucleic Acids Research.

In The Last Decade

Sandro Cosconati

134 papers receiving 4.3k citations

Hit Papers

Virtual screening with AutoDock: theory and practice 2010 2026 2015 2020 2010 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandro Cosconati Italy 38 2.5k 1.2k 561 488 339 136 4.3k
Liangren Zhang China 39 2.8k 1.1× 2.4k 1.9× 452 0.8× 456 0.9× 239 0.7× 236 6.2k
Donna M. Huryn United States 28 1.8k 0.7× 1.3k 1.0× 327 0.6× 291 0.6× 457 1.3× 80 3.5k
Fabrizio Giordanetto Sweden 29 2.7k 1.1× 807 0.7× 789 1.4× 524 1.1× 154 0.5× 73 4.1k
Scott D. Larsen United States 37 1.8k 0.7× 988 0.8× 274 0.5× 365 0.7× 333 1.0× 102 3.6k
Nadine Homeyer Germany 11 3.3k 1.3× 671 0.5× 1.1k 1.9× 501 1.0× 479 1.4× 18 4.9k
Bill R. Miller United States 11 2.3k 0.9× 535 0.4× 739 1.3× 345 0.7× 382 1.1× 23 3.7k
Michał Rostkowski Poland 12 3.6k 1.4× 628 0.5× 748 1.3× 391 0.8× 336 1.0× 25 5.3k
T. Dwight McGee United States 7 2.4k 1.0× 519 0.4× 813 1.4× 350 0.7× 420 1.2× 8 3.7k
Chresten R. Søndergaard Ireland 9 3.7k 1.5× 587 0.5× 716 1.3× 392 0.8× 335 1.0× 12 5.3k
David J. Maloney United States 43 3.3k 1.3× 991 0.8× 363 0.6× 905 1.9× 196 0.6× 140 5.6k

Countries citing papers authored by Sandro Cosconati

Since Specialization
Citations

This map shows the geographic impact of Sandro Cosconati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandro Cosconati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandro Cosconati more than expected).

Fields of papers citing papers by Sandro Cosconati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandro Cosconati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandro Cosconati. The network helps show where Sandro Cosconati may publish in the future.

Co-authorship network of co-authors of Sandro Cosconati

This figure shows the co-authorship network connecting the top 25 collaborators of Sandro Cosconati. A scholar is included among the top collaborators of Sandro Cosconati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandro Cosconati. Sandro Cosconati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paolo, Maria Luisa Di, Silvia Salerno, Stefania Sarno, et al.. (2025). 2-(Phenylamino)-7,8-dihydroquinazolin-5(6H)-one, a promising scaffold for MAO-B inhibitors with potential GSK3β targeting. European Journal of Medicinal Chemistry. 291. 117580–117580. 1 indexed citations
2.
Martelli, Alma, Eugenio Caradonna, Vincenzo Calderone, et al.. (2025). Trimethylamine N-Oxide (TMAO) Acts as Inhibitor of Endothelial Nitric Oxide Synthase (eNOS) and Hampers NO Production and Acetylcholine-Mediated Vasorelaxation in Rat Aortas. Antioxidants. 14(5). 517–517. 4 indexed citations
3.
Salerno, Silvia, Elisabetta Barresi, Emma Baglini, et al.. (2024). Pursuing Polypharmacology: Benzothiopyranoindoles as G-Quadruplex Stabilizers and Topoisomerase I Inhibitors for Effective Anticancer Strategies. ACS Medicinal Chemistry Letters. 15(11). 1875–1883.
4.
Feoli, Alessandra, Alessandra Cipriano, Ciro Milite, et al.. (2023). Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor. Journal of Medicinal Chemistry. 66(19). 13665–13683. 9 indexed citations
5.
Barresi, Elisabetta, Emma Baglini, Marianna Vitiello, et al.. (2023). A cyanine-based NIR fluorescent Vemurafenib analog to probe BRAFV600E in cancer cells. European Journal of Medicinal Chemistry. 256. 115446–115446. 6 indexed citations
6.
Bene, Alessandra Del, Stefano Tomassi, Francesco Merlino, et al.. (2023). Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS). Ultrasonics Sonochemistry. 95. 106360–106360. 8 indexed citations
7.
Previti, Santo, Roberta Ettari, Stefan Hammerschmidt, et al.. (2022). Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain. ACS Medicinal Chemistry Letters. 13(7). 1083–1090. 11 indexed citations
8.
Salerno, Silvia, Giorgio Amendola, Andrea Angeli, et al.. (2021). Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold. European Journal of Medicinal Chemistry. 220. 113490–113490. 13 indexed citations
9.
Baglini, Emma, Emanuela Berrino, Silvia Salerno, et al.. (2021). Tetrahydroquinazole-based secondary sulphonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IV, and IX, and computational studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1874–1883. 6 indexed citations
10.
Barresi, Elisabetta, Andrea Angeli, Emma Baglini, et al.. (2021). Carbonic anhydrase activation profile of indole-based derivatives. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1783–1797. 3 indexed citations
11.
Ettari, Roberta, Santo Previti, Giorgio Amendola, et al.. (2020). Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment. ChemMedChem. 15(16). 1552–1561. 16 indexed citations
12.
Merlino, Francesco, Stefano Tomassi, Ali Munaim Yousif, et al.. (2019). Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication. Organic Letters. 21(16). 6378–6382. 52 indexed citations
13.
Bruno, Agostino, Elisabetta Barresi, Nicola Simola, et al.. (2019). Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations. ACS Chemical Neuroscience. 10(8). 3805–3814. 24 indexed citations
14.
Milite, Ciro, Giorgio Amendola, Alessio Nocentini, et al.. (2019). Novel 2-substituted-benzimidazole-6-sulfonamides as carbonic anhydrase inhibitors: synthesis, biological evaluation against isoforms I, II, IX and XII and molecular docking studies. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1697–1710. 32 indexed citations
15.
Salerno, Silvia, Aída Nelly García‐Argáez, Elisabetta Barresi, et al.. (2018). New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors. European Journal of Medicinal Chemistry. 150. 446–456. 8 indexed citations
16.
Salerno, Silvia, Elisabetta Barresi, Giorgio Amendola, et al.. (2018). 4-Substituted Benzenesulfonamides Incorporating Bi/Tricyclic Moieties Act as Potent and Isoform-Selective Carbonic Anhydrase II/IX Inhibitors. Journal of Medicinal Chemistry. 61(13). 5765–5770. 21 indexed citations
17.
Milite, Ciro, Elisabetta Barresi, Eleonora Da Pozzo, et al.. (2017). Exploiting the 4-Phenylquinazoline Scaffold for the Development of High Affinity Fluorescent Probes for the Translocator Protein (TSPO). Journal of Medicinal Chemistry. 60(18). 7897–7909. 17 indexed citations
18.
Costa, Barbara, Sabrina Taliani, Eleonora Da Pozzo, et al.. (2017). Residence Time, a New parameter to Predict Neurosteroidogenic Efficacy of Translocator Protein (TSPO) Ligands: the Case Study of N,N‐Dialkyl‐2‐arylindol‐3‐ylglyoxylamides. ChemMedChem. 12(16). 1275–1278. 10 indexed citations
19.
Valente, Sérgio, Daniela Trisciuoglio, Maria Tardugno, et al.. (2013). tert‐Butylcarbamate‐Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells. ChemMedChem. 8(5). 800–811. 17 indexed citations
20.
Cosconati, Sandro, Luciana Marinelli, Antonio Lavecchia, & Ettore Novellino. (2007). Characterizing the 1,4-Dihydropyridines Binding Interactions in the L-Type Ca 2+ Channel:  Model Construction and Docking Calculations. Journal of Medicinal Chemistry. 50(7). 1504–1513. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026